Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TRIM16 |
| Upstream (Parents) |
|---|
| (<<) SERPINB5 → TRIM16 |
| (<<) PVALB → TRIM16 |
| (<<) C1orf116 → TRIM16 |
| (<<) ASAP2 → TRIM16 |
| (<<) FLNB → TRIM16 |
| Downstream (Children) |
|---|
| TRIM16 → SERPINB5 (>>) |
| TRIM16 → NMU (>>) |
| TRIM16 → SLC6A20 (>>) |
| TRIM16 → REN (>>) |
| TRIM16 → CELA3A (>>) |
| TRIM16 → FGFBP1 (>>) |
| TRIM16 → SWAP70 (>>) |
| TRIM16 → MINK1 (>>) |
| TRIM16 → CDH18 (>>) |
| TRIM16 → STMN4 (>>) |
| TRIM16 → FSCN3 (>>) |
| TRIM16 → MED27 (>>) |
| TRIM16 → FLNB (>>) |
